The main objective of this study was to investigate the relationship between the expression levels of Trop-2, CD47, and CD163, as assessed by immunohistochemistry in tumor tissue, and clinical outcomes and survival in TNBC, which is characterized by an aggressive clinical course and poor prognosis. Here, TACSTD2 is linked to neoplasm.